These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9029413)

  • 1. CSF inositol does not predict antidepressant response to inositol. Short communication.
    Levine J; Kurtzman L; Rapoport A; Zimmerman J; Bersudsky Y; Shapiro J; Belmaker RH; Agam G
    J Neural Transm (Vienna); 1996; 103(12):1457-62. PubMed ID: 9029413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind, controlled trial of inositol treatment of depression.
    Levine J; Barak Y; Gonzalves M; Szor H; Elizur A; Kofman O; Belmaker RH
    Am J Psychiatry; 1995 May; 152(5):792-4. PubMed ID: 7726322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up and relapse analysis of an inositol study of depression.
    Levine J; Barak Y; Kofman O; Belmaker RH
    Isr J Psychiatry Relat Sci; 1995; 32(1):14-21. PubMed ID: 7622343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
    Nierenberg AA; Ostacher MJ; Calabrese JR; Ketter TA; Marangell LB; Miklowitz DJ; Miyahara S; Bauer MS; Thase ME; Wisniewski SR; Sachs GS
    Am J Psychiatry; 2006 Feb; 163(2):210-6. PubMed ID: 16449473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inositol augmentation of lithium or valproate for bipolar depression.
    Eden Evins A; Demopulos C; Yovel I; Culhane M; Ogutha J; Grandin LD; Nierenberg AA; Sachs GS
    Bipolar Disord; 2006 Apr; 8(2):168-74. PubMed ID: 16542187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transition from the depressive stage to the manic stage during the treatment with antidepressive drugs].
    Koszewska I; Puzyński S
    Psychiatr Pol; 1991; 25(3-4):76-82. PubMed ID: 1821982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of antidepressant responses in patients with bipolar vs. unipolar depression: a meta-analytic review.
    Vázquez G; Tondo L; Baldessarini RJ
    Pharmacopsychiatry; 2011 Jan; 44(1):21-6. PubMed ID: 21031345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug resistance and various selected demographic and clinical characteristics of patients with endogenous depression].
    Puzyński S; Kalinowski A; Bidzińska E; Beresewicz M
    Psychiatr Pol; 1990; 24(5):16-22. PubMed ID: 2131472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Open preliminary study of new antidepressive compound: citalopram].
    Ropert R; Lôo H; Gay C
    Encephale; 1984; 10(3):131-4. PubMed ID: 6594229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Depressed patients in daily practice. 2: Drug treatment in depression].
    Jänicke U
    Z Arztl Fortbild (Jena); 1991 May; 85(10):484-6. PubMed ID: 1858398
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical comorbidity affects antidepressant treatment response in patients with melancholic depression.
    Pohle K; Domschke K; Roehrs T; Arolt V; Baune BT
    Psychother Psychosom; 2009; 78(6):359-63. PubMed ID: 19738401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium potentiation of antidepressant treatment.
    Louie AK; Meltzer HY
    J Clin Psychopharmacol; 1984 Dec; 4(6):316-21. PubMed ID: 6511998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bipolar depression: treatment options.
    Yatham LN; Kusumakar V; Parikh SV; Haslam DR; Matte R; Sharma V; Kennedy S
    Can J Psychiatry; 1997 Aug; 42 Suppl 2():87S-91S. PubMed ID: 9288441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.
    Alevizos B; Alevizos E; Leonardou A; Zervas I
    Psychiatriki; 2012; 23(2):143-8. PubMed ID: 22796912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant monotherapy in pre-bipolar depression; predictive value and inherent risk.
    O'Donovan C; Garnham JS; Hajek T; Alda M
    J Affect Disord; 2008 Apr; 107(1-3):293-8. PubMed ID: 17850879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report.
    Weilburg JB; Rosenbaum JF; Biederman J; Sachs GS; Pollack MH; Kelly K
    J Clin Psychiatry; 1989 Dec; 50(12):447-9. PubMed ID: 2600061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine versus venlafaxine in the treatment of unipolar and bipolar depression.
    Serafini G; Pompili M; Del Casale A; Mancini M; Innamorati M; Lester D; Girardi P; Tatarelli R
    Clin Ter; 2010; 161(4):321-7. PubMed ID: 20931154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-label uridine for treatment of depressed adolescents with bipolar disorder.
    Kondo DG; Sung YH; Hellem TL; Delmastro KK; Jeong EK; Kim N; Shi X; Renshaw PF
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):171-5. PubMed ID: 21486171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of lithium to augment antidepressant medication.
    Rouillon F; Gorwood P
    J Clin Psychiatry; 1998; 59 Suppl 5():32-9; discussion 40-1. PubMed ID: 9635546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.